Breast cancer therapy and cardiovascular risk: focus on trastuzumab
about
Biological agents in gastrointestinal cancers: adverse effects and their management.TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells.Localisation Microscopy of Breast Epithelial ErbB-2 Receptors and Gap Junctions: Trafficking after γ-Irradiation, Neuregulin-1β, and Trastuzumab Application.Therapeutic potentials of short interfering RNAs.Long noncoding RNA linc-ITGB1 promotes cell migration and invasion in human breast cancer.Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients.
P2860
Breast cancer therapy and cardiovascular risk: focus on trastuzumab
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Breast cancer therapy and cardiovascular risk: focus on trastuzumab
@ast
Breast cancer therapy and cardiovascular risk: focus on trastuzumab
@en
type
label
Breast cancer therapy and cardiovascular risk: focus on trastuzumab
@ast
Breast cancer therapy and cardiovascular risk: focus on trastuzumab
@en
prefLabel
Breast cancer therapy and cardiovascular risk: focus on trastuzumab
@ast
Breast cancer therapy and cardiovascular risk: focus on trastuzumab
@en
P2860
P921
P356
P1476
Breast cancer therapy and cardiovascular risk: focus on trastuzumab
@en
P2093
Aamer Sandoo
P2860
P304
P356
10.2147/VHRM.S69641
P407
P577
2015-04-07T00:00:00Z